Diosgenin attenuates metabolic-associated fatty liver disease through the hepatic NLRP3 inflammasome-dependent signaling pathway
-
Published:2024-09
Issue:
Volume:138
Page:112581
-
ISSN:1567-5769
-
Container-title:International Immunopharmacology
-
language:en
-
Short-container-title:International Immunopharmacology
Author:
Yu Wenfei,
Yin Guoliang,
Chen Suwen,
Zhang Xin,
Meng Decheng,
Wang Linya,
Liu Hongshuai,
Jiang Wenying,
Sun Yuqing,
Zhang FengxiaORCID